Andrejak C, Cottin V, Crestani B, Debieuvre D, Gonzalez-Bermejo J, Morelot-Panzini C, Stach B, Uzunhan Y, Maitre B, Raherison C
Service de pneumologie, CHU Amiens-Picardie, UR 4294 AGIR, université Picardie Jules-Verne, 80054 Amiens, France.
Service de pneumologie, centre de référence des maladies pulmonaires rares, Hospices Civils de Lyon, université de Lyon, INRAE, Lyon, France.
Rev Mal Respir. 2021 Jan;38(1):114-121. doi: 10.1016/j.rmr.2020.11.009. Epub 2020 Nov 27.
The French-speaking Respiratory Medicine Society (SPLF) proposes a guide for the management of possible respiratory sequelae in patients who have presented with SARS-CoV-2 pneumonia (COVID-19). The proposals are based on known data from previous epidemics, preliminary published data on post COVID-19 follow-up and on expert opinion. The proposals were developed by a group of experts and then submitted, using the Delphi method, to a panel of 22 pulmonologists. Seventeen proposals were validated ranging from additional examinations after the minimum assessment proposed in the SPLF monitoring guide, to inhaled or systemic corticosteroid therapy and antifibrotic agents. These proposals may evolve over time as knowledge accumulates. This guide emphasizes the importance of multidisciplinary discussion.
说法语的呼吸医学协会（SPLF）为曾患严重急性呼吸综合征冠状病毒2型肺炎（COVID-19）的患者可能出现的呼吸后遗症管理提出了一份指南。这些建议基于以往疫情的已知数据、关于COVID-19后随访的初步发表数据以及专家意见。这些建议由一组专家制定，然后采用德尔菲法提交给一个由22名肺科医生组成的小组。17项建议得到了验证，范围从SPLF监测指南中建议的最低评估后的额外检查，到吸入或全身用皮质类固醇疗法以及抗纤维化药物。随着知识的积累，这些建议可能会随时间而演变。本指南强调多学科讨论的重要性。
